Provided by Tiger Trade Technology Pte. Ltd.

Therapeutics

5.02
-0.1900-3.65%
Volume:153.24K
Turnover:784.18K
Market Cap:157.08M
PE:-1.22
High:5.31
Open:5.17
Low:5.02
Close:5.21
52wk High:50.40
52wk Low:4.54
Shares:31.29M
Float Shares:18.39M
Volume Ratio:1.01
T/O Rate:0.83%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-4.1300
EPS(LYR):-2.8503
ROE:-59.21%
ROA:-37.36%
PB:0.72
PE(LYR):-1.76

Loading ...

Alterity Therapeutics seeks ASX quotation for new ordinary shares

TIPRANKS
·
Aug 21

Chimeric Therapeutics Seeks ASX Quotation for 9.5 Million New Shares

TIPRANKS
·
Aug 21

HLS Therapeutics Earnings Call Highlights CV Growth

TIPRANKS
·
Aug 21

Bicycle Therapeutics Announces Board and Advisory Resignation

TIPRANKS
·
Aug 21

Qyuns Therapeutics (SEHK:2509) Stock Turns Profitable While Forecasts Cloud The Outlook

Simply Wall St.
·
Aug 21

Protagenic Therapeutics Advances PT00114 Toward U.S. IND

TIPRANKS
·
Aug 21

Sol-Gel Therapeutics: Steady SGT-610 Execution and Capital-Efficient Growth Strategy Drive Price Target Increase to $195 and Support Buy Rating

TIPRANKS
·
Aug 20

Vector Science and Therapeutics Files Patent for Orthopedic Regeneration Platform

TIPRANKS
·
Aug 20

Craig-Hallum bullish on Quince Therapeutics, initiates with a Buy

TIPRANKS
·
Aug 20

ProQR Therapeutics Price Target Announced at $8.00/Share by B of a Securities

Dow Jones
·
Aug 20

Cerenome Highlights Presentations at the 2026 SNO/ASCO CNS Metastases Conference Demonstrating Progress in Both Therapeutics and Diagnostics Business Lines

GlobeNewswire
·
Aug 20

CARsgen Therapeutics Holdings Ltd. (2171) Receives a Sell from Goldman Sachs

TIPRANKS
·
Aug 20

Arcturus Therapeutics Earnings Call Balances Progress, Pressure

TIPRANKS
·
Aug 20

Revive Therapeutics Moves to Settle Trade Debt Through Share Issuance

TIPRANKS
·
Aug 20

Chemomab Therapeutics Files Q2 2026 Results and Updates SEC Registrations

TIPRANKS
·
Aug 19

Qyuns Therapeutics Swings to Interim Profit on Surging Licensing Revenue

TIPRANKS
·
Aug 19

Chemomab Therapeutics Q2 EPS $(0.24) Misses $(0.15) Estimate

Benzinga Earnings
·
Aug 19

CARsgen Therapeutics (SEHK:2171) Stock Carries Premium Valuation Despite Ongoing Losses

Simply Wall St.
·
Aug 19

Chemomab Therapeutics Announces Second Quarter 2026 Financial Results and Provides Corporate Update

GlobeNewswire
·
Aug 19

BioMarin Acquisition of Alesta Therapeutics Reinforces Growth Strategy; Whitney Ijem Reiterates Buy Rating and Maintains $114 Price Target

TIPRANKS
·
Aug 19